Physician Nightmare, Coder Quandary: Bronchoalveolar Lavage

Original story posted on: July 23, 2018

Reporting bronchoalveolar lavage is all about location, location, location

Reporting bronchoalveolar lavage (BAL) has historically been a documentation nightmare for physicians and a quandary among coders. Physicians often use the right and left lung lobe sections to geographically indicate where the bronchoscope was advanced in the bronchial tree during BAL or other bronchial procedures.

Consequently, coders misunderstand the documentation to mean the physician has penetrated the lumen of the bronchus and entered the actual lung lobe encasing the bronchial tree. If documentation does not indicate that the wall of the bronchus was penetrated or that an instrument was used to push past the bronchioles (transbronchial) into the lung lobe, then references to lobes or lung lobes pertains to the location of the bronchoscope in the bronchial tree, not the actual lung lobe.

If documentation is missing or unclear regarding whether a procedure performed via bronchoscopy was endobronchial or transbronchial, the physician must be queried. All medical services must be sufficiently supported by documentation in the medical record.

Bronchoscopy is performed within the bronchus (endobronchial). The bronchus (bronchial tree) is a specific tubular structure encased in the right and left lung lobes. ICD-10-PCS has assigned specific body parts to the bronchial tree. If a fiberoptic bronchoscope is inserted into the bronchus and advanced into one of the smaller “branches” of the bronchial tree without a specific body part value, then code to the closest proximal branch of the bronchus that does have a specific body part value (ICD-10-PCS Official Coding Guidelines, B4.2, Branches of body parts). 

A bronchial lavage and BAL are essentially the same procedure, except for occasional minor differences. Both involve instilling a sterile solution into part of the bronchus via bronchoscope and aspirating the fluid back out to obtain samples for cytologic and microbacterial analysis – or simply to clear congested bronchial passages. Both are performed endoscopically and are reported with the root operation Drainage. Either one may be diagnostic, therapeutic, or both. Nevertheless, they are essentially one and the same for correct coding and reimbursement purposes. The only distinction may be the specific location of the bronchial tree where the lavage solution is introduced and/or the physician’s objective for performing the procedure.

Generally, saline is injected into the larger parts of the bronchial tree for bronchial lavage and into much smaller specific branches for retrieval of a more concentrated sample of fluid for a BAL. Bronchoalveolar lavage fluid (BALF) will render a more concentrated sample of alveolar cells and bacteria for cytologic analysis. The same amount of physician work is involved for both procedures; the bronchial (bronchus) wall is not penetrated, nor is any actual lung lobe tissue obtained. Because, anatomically, the alveolar duct provides a “bridge” between the bronchioles and alveoli clusters, there will be some alveolar cells (i.e., macrophages) present in the aspirated BALF.

By the same token, alveolar cells are also found in routine sputum samples. ICD-10-PCS has specific guidance that pertains to tubular bodies and has assigned body part values specific to the bronchial tree. It would be incorrect to report a lung lobe body part when lavage is performed exclusively within the bronchial tree.

In my opinion, the American Hospital Association’s (AHA’s) Coding Clinic® (CC) advice, published in 2017, titled Bronchial Lavage – Correction, contains misinformation regarding the body part that should be used for BAL. CC indicates that BAL involves washing out and sampling alveoli of the lung (small sacs within the lungs), concluding that a lung lobe body part value should be used for BAL, as it more accurately captures the objective (intent) of bronchoalveolar lavage. 

Firstly, there isn’t any specific “sampling alveoli” performed during BAL, as previously discussed. The aspirated fluid from the bronchial branches will inherently contain alveolar cells due to the bronchioles interfacing with the alveolar duct leading to alveoli clusters outside of the bronchial tree. Actual alveoli tissue is not biopsied (sampled). Secondly, the objective (intent) of a procedure may influence assignment of the root operation value. Conversely, the body part value should reflect the site of the procedure. 

It is important to note that a bronchial lavage/bronchoalveolar lavage reported with a lung lobe body part can trigger a DRG change, resulting in a very significant overpayment. Consequently, this issue may be scrutinized by the Centers for Medicare & Medicaid Services (CMS), Recovery Audit Contractors (RACs), and/or the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) as an improper payment target. 

I have contacted Coding Clinic regarding this important issue, and I am awaiting a response. In the meantime, facilities are receiving improper reimbursement for BALs reported with a lung lobe body part value.  

Official ICD-10-PCS Coding Guidelines

B4.1c: If a procedure is performed on a continuous section of a tubular body part, code the body part value corresponding to the furthest anatomical site from the point of entry.

Example: A procedure performed on a continuous section of artery from the femoral artery to the external iliac artery with the point of entry at the femoral artery is coded to the external iliac body part.

B4.2: Where a specific branch of a body part does not have its own body part value in PCS, the body part is typically coded to the closest proximal branch that has a specific body part value.


Program Note:

Listen to Stacey Elliott today on Talk Ten Tuesday, 10-10:30 a.m. ET report on the proper coding of bronchoalveolar lavage.

Comment on this article

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.
Stacey Elliott, CCS, CPC

Stacey Elliott, CCS, CPC, has more than 30 years of work experience in coding, compliance, and auditing. She currently provides audit and educational services to a large multi-facility organization. Stacey specializes in research and analysis of industry rules, regulations, and guidance in support of quality clinical documentation integrity (CDI) and accurate ethical coding practices.

Related Stories

  • Medicare Expenditure Projections
    Expenditures are expected to reach more than $6 trillion by 2028. Quoting from a recent press release, I noted that the Centers for Medicare & Medicaid Services (CMS) said, reflected by the below bullet points, that: Major Findings for National…
  • Medicare’s Accelerated and Advanced Payment Loan Repayment Has Started
    This is updates an ICD10monitor story posted in September 2020. The repayment began March 30, 2021. In March 2020, the Centers for Medicare and Medicaid Services (CMS) expanded the Accelerated and Advanced Payment Program (AAP) due to the COVID-19 Public Health…
  • A Warning from the OIG about Higher-Severity DRG Shift
    This OIG audit is an opportunity for us to be introspective. In February, a report came out from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) regarding their concern about an apparent increase in…